Search Results - niladri+sinha

1 Results

Sort By:

Targeted Antineoplastic Therapeutic for Cancers with High Translation Rates

Value Proposition:Targeted cancer therapeutic and combination therapy to prevent resistanceTarget cancer cell’s vulnerable translation processesTarget aggressive cancers with poor prognoses at present Technology DescriptionThe disclosed technology addresses the major challenge of identifying selective drug therapies that kill cancer cells, without affecting...

Published: 6/27/2025 | Inventor(s): Rachel Green, Sergi Regot, Niladri Sinha, Connor McKenney

Keywords(s):

Category(s): Clinical and Disease Specializations, Clinical and Disease Specializations > Oncology, Technology Classifications > Therapeutic Modalities